Waasila Jassat to Seroepidemiologic Studies
This is a "connection" page, showing publications Waasila Jassat has written about Seroepidemiologic Studies.
Connection Strength
0,290
-
Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study. Viruses. 2023 02 21; 15(3).
Score: 0,051
-
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop Med Int Health. 2022 Jun; 27(6):564-573.
Score: 0,049
-
SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa. Emerg Infect Dis. 2022 May; 28(5):1055-1058.
Score: 0,048
-
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. N Engl J Med. 2022 04 07; 386(14):1314-1326.
Score: 0,048
-
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020. S Afr Med J. 2021 11 05; 111(11):1078-1083.
Score: 0,047
-
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021. Emerg Infect Dis. 2021 12; 27(12):3020-3029.
Score: 0,046